• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

Vitamin D supplementation not supported to treat first-episode psychosis

byJake EngelandMichael Pratte
February 22, 2022
in Chronic Disease, Endocrinology, Psychiatry
Reading Time: 2 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. The DFEND double-blind, randomized controlled trial revealed that Vitamin D supplementation led to no improvements in clinical outcomes at 6-months, as measured by the Positive and Negative Syndrome Scale, among patients with first-episode psychosis compared to placebo.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Recent evidence indicates that individuals with psychosis are more likely to be Vitamin D deficient than the remainder of the population. Low Vitamin D is associated with brain-related changes, which has resulted in speculation that optimizing Vitamin D levels may improve outcomes. However, there has yet to be a study demonstrating the benefit of Vitamin D supplementation for psychosis. The DFEND randomized controlled trial investigated whether Vitamin D supplementation can improve clinical outcomes in patients with first-episode psychosis (FEP) compared to placebo. The primary outcome (measurement of clinical improvement) was Positive and Negative Syndrome Scale (PANSS) at 6 months, where a reduction in scores indicates improvement. PANSS contains positive, negative, and general psychopathology subscores. Participants (149 included in the primary analysis) diagnosed with functional psychosis were recruited from January 19, 2016 until June 14, 2019 and were randomized 1:1 to receive 120 000 IU of Vitamin D3 (cholecalciferol) or placebo. At 6 months, there was no group difference in PANSS total score between the Vitamin D group versus the placebo group (mean difference [MD]: 3.57 [95% CI: -1.11 to 8.25]; p= 0.13). When breaking down PANSS components, no group difference was found in PANSS positive score (MD: 0.68 [95% CI: -0.69 to 1.99]; p= 0.34), PANSS negative score (MD: 1.56 [95% CI: -0.31 to 3.44]; p= 0.10), and PANSS general psychopathology score (MD: 1.31 [95% CI: -1.42 to 4.05]; p= 0.34) at 6 months. Furthermore, no differences were found in Global Assessment of Function symptom (MD: 0.02 [95% CI: -4.60 to 4.94]) or disability (MD: -0.01 [95% CI: -5.25 to 5.23]) scores and cardiometabolic risk factors (waist circumference, body mass index, glycated hemoglobin, and total cholesterol) between groups. Overall, the DFEND clinical trial demonstrated that Vitamin D supplementation in patients with FEP does not improve mental health outcomes compared to placebo. One limitation of this study is that outcomes were assessed for 6-months, however, vitamin-D-related improvements may require longer term observation of treatment and follow-up.

Click to read the study in JAMA Network Open

Relevant Reading: Vitamin D supplementation in chronic schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled clinical trial

Image: PD

RELATED REPORTS

The incidence of psychotic disorders has increased in more recent birth cohorts

2 Minute Medicine Rewind February 9, 2026

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Psychosisvitamin dvitamin D3
Previous Post

Prevalence of major depressive and anxiety disorders has increased during the COVID-19 pandemic

Next Post

Prevalence of diabetes mellitus in China, 2013-2018

RelatedReports

Psychosis in young people collage: a calm young woman in profile beside a branching tree drawn in teal dots on blue paper
Chronic Disease

The incidence of psychotic disorders has increased in more recent birth cohorts

February 9, 2026
Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer: A Phase 2 Clinical Trial
Weekly Rewinds

2 Minute Medicine Rewind February 9, 2026

February 9, 2026
AAP continues to recommend fluoride for prevention of dental caries
Obstetrics

Lower vitamin D levels in the second and third trimesters are associated with an increased risk of early childhood caries in children

January 13, 2026
AAP continues to recommend fluoride for prevention of dental caries
Weekly Rewinds

2 Minute Medicine Rewind December 8th, 2025

February 2, 2026
Next Post

Prevalence of diabetes mellitus in China, 2013-2018

Rates of surgical site infections are similar between chlorhexidine and iodine-based skin preparations

Adjuvant treatment with catechol-O-methyltransferase inhibitors inferior to monoamine oxidase type B inhibitors or dopamine agonists in patients with Parkinson disease uncontrolled by levodopa therapy

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Interim global phase 2 AZUR-1 results show durable responses with dostarlimab monotherapy in untreated MSI-H/dMMR stage II/III locally advanced rectal cancer
  • AI health chatbot shows no benefit for perinatal anxiety or depression
  • ADCE-D01 showed a 30% objective response rate in topline phase 1 results for previously treated advanced soft tissue sarcoma
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.